Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J AIDS HIV Treat ; 6(1): 11-27, 2024.
Article in English | MEDLINE | ID: mdl-38845818

ABSTRACT

This review underscores the important role of nutrition in enhancing the management of Human Immunodeficiency Virus type 1 (HIV-1). Highlighting the efficacy of dietary interventions, including, the importance of omega-3 fatty acids, vitamins D and B-12, and the Mediterranean diet, we delineate how these beneficial nutritional strategies can improve the effectiveness of combined antiretroviral therapy (cART), mitigate its side effects, and ameliorate metabolic disorders in people living with HIV-1 (PLWH). Our review advocates for the integration and implementation of personalized nutritional assessments into the care plan for PLWH, proposing actionable strategies for healthcare providers in HIV-1 field. Summarizing the current standing of the relevance of the nutritional and well-planned diet recommended for the PLWH and emphasizing on the future research directions, this review establishes a foundation for nutrition as a cornerstone in comprehensive HIV-1 management. Our review aims to improve patients' health outcomes and overall quality of life for PLWH.

2.
J Diet Suppl ; 19(5): 587-602, 2022.
Article in English | MEDLINE | ID: mdl-33759701

ABSTRACT

The primary purpose was to determine the separate and combined effects of creatine and caffeine supplementation during resistance training on body composition and muscle performance in trained young adults. Twenty-eight participants were randomized to supplement with creatine and caffeine (CR-CAF; n = 9, 22 ± 4 years; 0.1 g·kg-1·d-1 of creatine monohydrate + 3 mg·kg-1·d-1 of caffeine anhydrous micronized powder); creatine (CR; n = 7, 22 ± 4 years, 0.1 g·kg-1·d-1 of creatine + 3 mg·kg-1·d-1 of micronized cellulose), caffeine (CAF; n = 6, 19 ± 1 years, 3 mg·kg-1·d-1 of caffeine + 0.1 g·kg-1·d-1 of maltodextrin) or placebo (PLA; n = 6, 23 ± 7 years, 0.1 g·kg-1·d-1 of maltodextrin + 3 mg·kg-1·d-1 micronized cellulose) one hour prior to performing resistance training for 6 weeks. Before and after training and supplementation, fat-free and fat mass (air-displacement plethysmography), muscle thickness (elbow and knee flexors and extensors; ultrasound), muscle strength (1-repetition maximum [1-RM] for the leg press and chest press), and endurance (one set of repetitions to volitional fatigue using 50% baseline 1-RM for leg press and chest press) were assessed. There was a group x time interaction (p = 0.049) for knee extensor muscle thickness with CR experiencing an increase over time with no changes in the other groups. There were no other between group differences for any variable. In conclusion, creatine supplementation and resistance training results in a small improvement in knee extensor muscle accretion in trained young adults.


Subject(s)
Creatine , Resistance Training , Body Composition , Caffeine/pharmacology , Cellulose , Dietary Supplements , Double-Blind Method , Fatigue , Humans , Muscle Strength , Muscle, Skeletal , Physical Exertion , Resistance Training/methods , Young Adult
3.
Plants (Basel) ; 11(1)2021 Dec 21.
Article in English | MEDLINE | ID: mdl-35009009

ABSTRACT

Inflammatory bowel disease (IBD) is a group of complex chronic inflammatory conditions affecting the gastrointestinal tract. It is linked to a number of genetic and environmental factors able to perturb the immune-microbiome axis. Diet is the most investigated variable both for its role in the etiology of IBD and for its beneficial potential in the treatment of the symptoms. Dietary products may influence intestinal inflammation through different mechanisms of action, such as the modulation of inflammatory mediators, the alteration of gene expression, changes in gut permeability, and modifications in enteric flora composition. A consisting number of studies deal with the link between nutrition and microbial community, and particular attention is paid to plant-based foods. The effects of the dietary intake of different fruits have been investigated so far. This review aims to present the most recent studies concerning the beneficial potential of fruit consumption on human gut microbiota. Investigated plant species are described, and obtained results are presented and discussed in order to provide an overview of both in vitro and in vivo effects of fruits, their juices, and freeze-dried powders.

4.
Pathog Dis ; 73(8): ftv062, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26333571

ABSTRACT

Lymphangiogenesis and concurrent angiogenesis are essential in supporting proliferation and survival of AIDS-related lymphomas, which are often metastatic. In vitro studies suggest a candidate angiogienic and lymphangiogenic factor encoded by HIV: the matrix protein p17. p17 accumulates in lymph nodes of patients even when they are undergoing highly active antiretroviral therapy. p17 has been found to affect immune cells, and recent data showed that a variant p17, called S75X, induces cell growth by triggering MAPK/ERK and PI3K/AKT pathways. We tested the in vivo angiogenic activity of p17 by injecting it in Matrigel plugs in nude mice. Plugs were retrieved 7 days after injection, and assessed macroscopically, and by light and confocal microscopy. Our data revealed that both reference and S75X variant p17 promote angiogenesis and lymphangiogenesis in vivo. Our results suggest that the induction of angiogenesis and lymphangiogenesis by HIV-1 p17 may generate a favorable microenvironment that could trigger tumor growth and maintenance. Moreover, the presence of adipocytes infiltration observed at the histological level suggests a possible interplay between angiogenesis, lymphangiogenesis and adipogenesis. These findings offer new opportunities for the development of treatment strategies to combat HIV-related cancers.


Subject(s)
Adipogenesis/drug effects , HIV Antigens/metabolism , HIV-1/physiology , Lymphangiogenesis/drug effects , Neovascularization, Pathologic/chemically induced , gag Gene Products, Human Immunodeficiency Virus/metabolism , Animals , HIV Antigens/administration & dosage , Mice, Nude , Microscopy , gag Gene Products, Human Immunodeficiency Virus/administration & dosage
5.
Arterioscler Thromb Vasc Biol ; 34(4): 846-56, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24482377

ABSTRACT

OBJECTIVE: AIDS-related lymphomas are high grade and aggressively metastatic with poor prognosis. Lymphangiogenesis is essential in supporting proliferation and survival of lymphoma, as well as tumor dissemination. Data suggest that aberrant lymphangiogenesis relies on action of HIV-1 proteins rather than on a direct effect of the virus itself. HIV-1 matrix protein p17 was found to accumulate and persist in lymph nodes of patients even under highly active antiretroviral therapy. Because p17 was recently found to exert a potent proangiogenic activity by interacting with chemokine (C-X-C motif) receptors 1 and 2, we tested the prolymphangiogenic activity of the viral protein. APPROACH AND RESULTS: Human primary lymph node-derived lymphatic endothelial cells were used to perform capillary-like structure formation, wound healing, spheroids, and Western blot assays after stimulation with or without p17. Here, we show that p17 promotes lymphangiogenesis by binding to chemokine (C-X-C motif) receptor-1 and chemokine (C-X-C motif) receptor-2 expressed on lymph node-derived lymphatic endothelial cells and activating the Akt/extracellular signal-regulated kinase signaling pathway. In particular, it was found to induce capillary-like structure formation, sprout formation from spheroids, and increase lymph node-derived lymphatic endothelial cells motility. The p17 lymphangiogenic activity was, in part, sustained by activation of the endothelin-1/endothelin receptor B axis. A Matrigel plug assay showed that p17 was able to promote the outgrowth of lymphatic vessels in vivo, demonstrating that p17 directly regulates lymphatic vessel formation. CONCLUSIONS: Our results suggest that p17 may generate a prolymphangiogenic microenvironment and plays a role in predisposing the lymph node to lymphoma growth and metastasis. This finding offers new opportunities to identify treatment strategies in combating AIDS-related lymphomas.


Subject(s)
Endothelial Cells/metabolism , Endothelin-1/metabolism , Endothelium, Lymphatic/metabolism , HIV Antigens/metabolism , Lymphangiogenesis , Lymphatic Vessels/metabolism , Lymphoma, AIDS-Related/metabolism , Receptor, Endothelin B/metabolism , gag Gene Products, Human Immunodeficiency Virus/metabolism , Animals , Cell Movement , Endothelial Cells/virology , Endothelium, Lymphatic/virology , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Humans , Lymphatic Vessels/physiopathology , Lymphatic Vessels/virology , Lymphoma, AIDS-Related/physiopathology , Lymphoma, AIDS-Related/virology , Mice , Mice, Inbred C57BL , Proto-Oncogene Proteins c-akt/metabolism , Receptors, Interleukin-8A/metabolism , Receptors, Interleukin-8B/metabolism , Signal Transduction , Spheroids, Cellular , Time Factors , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL
...